Clinical Trial Update: Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate how a GLP-1 receptor agonist affects brain insulin responsiveness in individuals spanning normal weight to obesity, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Normal Weight, Overweight and Obesity | NA | Status: RECRUITING